{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:45:27Z","timestamp":1775627127566,"version":"3.50.1"},"reference-count":33,"publisher":"American Association for Cancer Research (AACR)","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>High-risk multiple myeloma is genomically unstable, comprising heterogeneous populations of tumor cells that evolve over time. Light chain escape (LCE) is a clinical phenomenon observed when light chains rise separately from M-spike values, which implies divergent tumor evolution. We sought to understand LCE by performing high-depth transcriptomic and phenotypic studies. We performed single-cell RNA-sequencing (scRNA-seq) and ex vivo drug sensitivity profiling on serial bone marrow biopsies from a patient with LCE at diagnosis, first relapse, and relapsed\/refractory timepoints. scRNA-seq revealed distinct transcriptomic subpopulations with phenotypes that could be tracked separately by clinical serum light chain and M-spike values. Genes differentially expressed between subpopulations were assessed for generalizable effects on prognosis from the Multiple Myeloma Research Foundation CoMMpass and GSE24080 datasets. Notably, the LCE subpopulation exhibited gene expression profile featuring prominent LAMP5 overexpression, which was associated with risk for osteolytic bone lesions. Ex vivo drug sensitivity testing displayed differential sensitivity of the subpopulations. Copy number variant inference showed that the transcriptomic subpopulation underlying LCE was related to a genetic subclone that evolved over time. Our findings illustrate that malignant subpopulations underly LCE in multiple myeloma. These studies imply that LCE and LAMP5 gene overexpression portends for increased risk of osteolytic bone disease and adverse prognosis, findings that were confirmed in the subset of patients from the CoMMpass database with LCE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>scRNA-seq was used to study a patient with high-risk multiple myeloma featuring LCE. LCE was rooted in a transcriptomic subpopulation that corresponded to a genetic subclone and established novel links between LCE and LAMP5 overexpression to osteolysis and prognosis, validated in RNA-seq databases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0170","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T09:31:22Z","timestamp":1734600682000},"page":"106-118","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1920-6319","authenticated-orcid":false,"given":"Denis","family":"Ohlstrom","sequence":"first","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."},{"name":"2Biomedical Sciences and Biotechnology, Graduate School, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1384-3309","authenticated-orcid":false,"given":"Zachary J.","family":"Walker","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7766-5831","authenticated-orcid":false,"given":"Abhishek","family":"Pandey","sequence":"additional","affiliation":[{"name":"3Hematology-Oncology Fellowship Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-4752","authenticated-orcid":false,"given":"Lorraine N.","family":"Davis","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3132-1491","authenticated-orcid":false,"given":"Krysta L.","family":"Engel","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-3356","authenticated-orcid":false,"given":"Zenggang","family":"Pan","sequence":"additional","affiliation":[{"name":"4Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3248-7530","authenticated-orcid":false,"given":"Peter A.","family":"Forsberg","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6996-0497","authenticated-orcid":false,"given":"Tomer M.","family":"Mark","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2928-6308","authenticated-orcid":false,"given":"Austin E.","family":"Gillen","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-7174","authenticated-orcid":false,"given":"Daniel W.","family":"Sherbenou","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado."},{"name":"5University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"2025051308482076800_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/2040620718775629","article-title":"Update on the role of lenalidomide in patients with multiple myeloma","volume":"9","author":"Holstein","year":"2018","journal-title":"Ther Adv Hematol"},{"key":"2025051308482076800_bib2","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"2025051308482076800_bib3","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1200\/JCO.21.02614","article-title":"Second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma: a European myeloma network (EMN) report within the HARMONY project","volume":"40","author":"D\u2019Agostino","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025051308482076800_bib4","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1182\/blood-2013-12-542662","article-title":"Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome","volume":"123","author":"Brioli","year":"2014","journal-title":"Blood"},{"key":"2025051308482076800_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3324\/haematol.11133","article-title":"Demonstration of changes in plasma cell subsets in multiple myeloma","volume":"92","author":"Ayliffe","year":"2007","journal-title":"Haematologica"},{"key":"2025051308482076800_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma","volume":"120","author":"Keats","year":"2012","journal-title":"Blood"},{"key":"2025051308482076800_bib7","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1038\/ncomms3997","article-title":"Heterogeneity of genomic evolution and mutational profiles in multiple myeloma","volume":"5","author":"Bolli","year":"2014","journal-title":"Nat Commun"},{"key":"2025051308482076800_bib8","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","article-title":"Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma","volume":"24","author":"Ledergor","year":"2018","journal-title":"Nat Med"},{"key":"2025051308482076800_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-022-28266-z","article-title":"Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma","volume":"13","author":"Merz","year":"2022","journal-title":"Nat Commun"},{"key":"2025051308482076800_bib10","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/bloodadvances.2019000122","article-title":"Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression","volume":"4","author":"Walker","year":"2020","journal-title":"Blood Adv"},{"key":"2025051308482076800_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/1078-0432.CCR-20-2246","article-title":"Exploiting protein translation dependence in multiple myeloma with omacetaxine-based therapy","volume":"27","author":"Walker","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2025051308482076800_bib12","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2025051308482076800_bib13","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/bty1044","article-title":"M3Drop: dropout-based feature selection for scRNASeq","volume":"35","author":"Andrews","year":"2019","journal-title":"Bioinformatics"},{"key":"2025051308482076800_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst"},{"key":"2025051308482076800_bib15","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2025051308482076800_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2025051308482076800_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2025051308482076800_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.1665","article-title":"The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models","volume":"28","author":"Shi","year":"2010","journal-title":"Nat Biotechnol"},{"key":"2025051308482076800_bib19","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"Shaughnessy","year":"2007","journal-title":"Blood"},{"key":"2025051308482076800_bib20","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/leu.2014.232","article-title":"Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma","volume":"28","author":"Heuck","year":"2014","journal-title":"Leukemia"},{"key":"2025051308482076800_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41591-021-01232-w","article-title":"Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing","volume":"27","author":"Cohen","year":"2021","journal-title":"Nat Med"},{"issue":"Suppl 15","key":"2025051308482076800_bib22","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1200\/JCO.2020.38.15_suppl.8524","article-title":"Prospective evaluation of spatial heterogeneity at single cell resolution in multiple myeloma","volume":"38","author":"Merz","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025051308482076800_bib23","doi-asserted-by":"crossref","first-page":"723016","DOI":"10.3389\/fcell.2021.723016","article-title":"S100 calcium binding protein family members associate with poor patient outcome and response to proteasome inhibition in multiple myeloma","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025051308482076800_bib24","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/leu.2014.13","article-title":"Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma","volume":"28","author":"Melchor","year":"2014","journal-title":"Leukemia"},{"key":"2025051308482076800_bib25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/bloodadvances.2019000779","article-title":"Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma","volume":"4","author":"Ziccheddu","year":"2020","journal-title":"Blood Adv"},{"key":"2025051308482076800_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood-2018-04-842880","article-title":"The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma","volume":"132","author":"Rasche","year":"2018","journal-title":"Blood"},{"key":"2025051308482076800_bib27","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","article-title":"Prognostic significance of copy-number alterations in multiple myeloma","volume":"27","author":"Avet-Loiseau","year":"2009","journal-title":"J Clin Oncol"},{"key":"2025051308482076800_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41408-019-0199-3","article-title":"Deciphering the chronology of copy number alterations in Multiple Myeloma","volume":"9","author":"Aktas","year":"2019","journal-title":"Blood Cancer J"},{"key":"2025051308482076800_bib29","doi-asserted-by":"crossref","first-page":"e81184","DOI":"10.7554\/eLife.81184","article-title":"Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling","volume":"12","author":"Farrell","year":"2023","journal-title":"Elife"},{"key":"2025051308482076800_bib30","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.3324\/haematol.2018.209999","article-title":"The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged","volume":"104","author":"Storti","year":"2019","journal-title":"Haematologica"},{"key":"2025051308482076800_bib31","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1182\/blood-2004-11-4201","article-title":"Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome","volume":"105","author":"Ladetto","year":"2005","journal-title":"Blood"},{"key":"2025051308482076800_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajh.20460","article-title":"Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival","volume":"80","author":"Cetin","year":"2005","journal-title":"Am J Hematol"},{"key":"2025051308482076800_bib33","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3390\/cancers13133189","article-title":"Pathogenetic and prognostic implications of increased mitochondrial content in multiple myeloma","volume":"13","author":"Ruiz-Heredia","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0170\/3526185\/crc-24-0170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/1\/106\/3533916\/crc-24-0170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/1\/106\/3533916\/crc-24-0170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:48:31Z","timestamp":1747126111000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/1\/106\/751121\/Single-Cell-RNA-Sequencing-before-and-after-Light"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0170","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.28219540","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219552","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219564","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219576","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219570","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219537","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219549","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219555","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219567","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050390","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219579","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219525","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050360","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050372","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050384","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219519","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050354","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050366","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050378","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050357","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050369","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219573","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219531","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219543","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219561","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219516","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219528","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219522","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219534","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219546","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28219558","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050381","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050393","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050351","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050363","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050375","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050387","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7629400","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}